Altered Fos-like immunoreactivity in terminal regions of the mesotelencephalic dopamine system is associated with reappearance of tyrosine hydroxylase immunoreactivity at the sites of focal 6-hydroxydopamine lesions in the nucleus accumbens.
The present study was undertaken in order to determine whether unilateral 6-hydroxydopamine (6-OHDA) lesions in the nucleus accumbens (Acb) affect basal Fos-like immunoreactivity (-LI) in terminal regions of the mesotelencephalic dopamine system. It was hypothesized that dopamine depletion in the Acb would alter activation of mesotelencephalic dopamine neurons perhaps via the striatomesencephalic GABAergic pathway, and that this may be detected as altered basal Fos-LI in mesotelencephalic terminal regions. 6-OHDA treatment effectively depleted tyrosine hydroxylase (TH)-LI in well-circumscribed areas of the Acb at 14 days post-lesion, but at 25 days post-lesion all animals showed a reappearance of TH-LI staining in the lesioned region. When data from a number of mesotelencephalic terminals regions was pooled. Fos-LI cell density was higher in the sham and lesion 14-day groups and sham 25-day group than both the 25-day lesion group and untreated controls. The present study demonstrates that unilateral sham and 6-OHDA lesions in the Acb may have repercussions throughout the mesotelencephalic dopamine system. Further investigation is necessary to determine whether reappearance of TH-LI at the lesion site contributes to the return of Fos-LI to basal levels.